(Q31104353)

28 June 2017

1 reference

title

The potential of gene transfer into primary B-CLL cells using recombinant virus vectors (English)

1 reference

B-cell chronic lymphocytic leukemia

28 June 2017

0 references

1 reference

Wendtner CM

1

1 reference

28 June 2017

Kofler DM

2

1 reference

28 June 2017

Mayr C

3

1 reference

28 June 2017

Bund D

4

1 reference

28 June 2017

Hallek M

5

1 reference

28 June 2017

publication date

1 May 2004

1 reference

28 June 2017

1 reference

28 June 2017

volume

45

1 reference

28 June 2017

issue

5

1 reference

28 June 2017

page(s)

897-904

1 reference

Monocyte-derived dendritic cells in chronic lymphocytic leukemia

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Acquired CD40-ligand deficiency in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Transfection and gene expression in normal and malignant primary B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Novel tools for production and purification of recombinant adenoassociated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Real-time single-molecule imaging of the infection pathway of an adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Activation and immortalization of leukaemic B cells by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Adeno-associated virus vectors preferentially transduce cells in S phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Development and application of herpes simplex virus vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Chronic lymphocytic leukemia B cells are highly sensitive to infection by herpes simplex virus-1 via herpesvirus-entry-mediator A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Working toward an adenoviral vector testing standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Efficient gene transfer and expression in primary B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001638896

10.1080/10428190310001638896

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference